Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Solvay Pharmaceuticals, Inc. announced the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an atypical antipsychotic that was reviewed for the acute treatment of schizophrenia, as well as the maintenance of stable adult patients.
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
deCODE scientists have identified a sequence variant responsible for virtually all cases of a major subtype of glaucoma. The protein encoded by the gene appears to have a clear pathophysiologal role.
Business solution provider Accentia Technologies said it has bagged its first order worth euro 2.1 million (Rs 11.61 crore) in the UK for Hospital Process Management suite to improve the quality of clinical care.
The RAND Corporation and Health Dialog Services Corporation today announced an alliance that will entitle Health Dialog to exclusive, worldwide rights to integrate select RAND quality measures into its existing provider performance measurement tools and care management services.
Synova Healthcare Group, Inc. announced that the Today(r) Sponge, the first and only female contraceptive to combine a spermicide with a barrier contraceptive, is unveiling its exciting new look this summer.
National Jewish Medical and Research Center discharged patient Andrew Speaker at 6 a.m. Thursday, July 26, after the successful completion of his in-patient treatment for multi-drug-resistant tuberculosis.
Nearly three million seniors would lose their Medicare Advantage coverage under legislation proposed in the House of Representatives, according to the non-partisan Congressional Budget Office (CBO).
America?s Health Insurance Plans (AHIP) announced it has launched a national television advertising campaign in which seniors speak about the effect that cuts to Medicare Advantage would have on their health security and urge concerned citizens to ask Congress to protect the program.